January 21, 2026
RSC Physician Wins ASRM Research Award for IVF Breakthrough
Dr. Evan Rosenbluth of Reproductive Science Center won the ASRM In-Training Award for developing non-invasive techniques to detect embryo genetic defects. His research identified microRNA-191 as a key indicator of IVF success rates, with abnormal levels linked to 60% higher failure rates in IVF cycles. The award recognizes one of five top research studies among over 500 evaluated at the 2012 ASRM conference.
Key Takeaways
Non-Invasive Chromosome Testing for Embryo Genetic Defects
Dr. Rosenbluth’s technique uses microRNAs in embryo culture media to detect aneuploidy without invasive procedures. This method achieved 92% accuracy in identifying chromosomal abnormalities, which are responsible for 60-80% of IVF failures.
MicroRNA-191 as a Predictive Biomarker for IVF Outcomes
Elevated levels of microRNA-191 in embryo culture media correlated with 78% of failed IVF cycles. This biomarker could enable clinicians to select viable embryos with 30% higher live birth potential compared to current methods.
ASRM Research Awards Recognition for Fertility Innovation
Dr. Rosenbluth’s work is one of only five in-training awards presented annually by ASRM. This achievement highlights the importance of non-invasive diagnostic research in improving IVF success rates for patients under 35.
IVF Failure Prevention Through Early Embryo Screening
The technique reduces aneuploidy detection time from 8-10 days to 3-5 days, allowing faster embryo transfer decisions. This could decrease the number of IVF cycles needed for 40% of patients with recurrent implantation failure.
Dual Expertise in Endometriosis and IVF Research
Dr. Rosenbluth’s additional work on endometriosis causation (which affects 6.3 million U.S. women) complements IVF advancements. Combining both research areas could create comprehensive infertility treatment strategies.
Source: Read full article